MGMT-UNMETHYLATED GLIOBLASTOMA

Clinical trials for MGMT-UNMETHYLATED GLIOBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new MGMT-UNMETHYLATED GLIOBLASTOMA trials appear

Sign up with your email to follow new studies for MGMT-UNMETHYLATED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

New hope for aggressive brain tumors: immune therapy trial challenges standard care

Disease control Completed

This study tested if a new type of treatment called immunotherapy could work better than standard chemotherapy for adults newly diagnosed with a specific, aggressive form of brain cancer (glioblastoma) that does not respond well to usual drugs. Patients received either the standa…

Matched conditions: MGMT-UNMETHYLATED GLIOBLASTOMA

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

MGMT-UNMETHYLATED GLIOBLASTOMA

Get alerted when new MGMT-UNMETHYLATED GLIOBLASTOMA trials appear

New hope for aggressive brain tumors: immune therapy trial challenges standard care